Identification and validation of novel cerebrospinal fluid protein biomarkers for early Alzheimer's disease using proteomics and ELISA: a multi-institutional collaborative study

Disease Research Center, University of Washington Medical Center, Seattle, WA, USA; Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan; Immuno-Biological Laboratories Co., Ltd. (IBL), Fujioka, Japan; Department of Neurology, Emory Alzheimer’s Disease Research Center, Emory University, Atlanta, GA, USA; Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Departments of Neurology and Neuropathology, University of Washington, Seattle, WA, USA; Department of Psychiatry, Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Departments of Neurology and Psychiatry, Mount Sinai School of Medicine, Alzheimer’s Disease Research Center, New York, NY, USA. Contact e-mail: sahata07@ hotmail.com